4DMedical Limited (ASX:4DX) Secures New Industry Contracts and Gains Congressional Recognition
4DMedical Limited (ASX:4DX) wins new industry contracts and is highlighted in US Congressional testimony on VA Healthcare modernization.
Category: Healthcare
Osteopore Limited (ASX:OSX) Secures EU MDR Approval for Custom Implants
Osteopore (ASX:OSX) secures EU MDR approval for custom orthopaedic and cranial implants, expanding its market in Europe.
Nyrada Inc. (ASX:NYR) Progresses Phase I Clinical Trial
Nyrada Inc. (ASX:NYR) advances its Phase I clinical trial to the second cohort, anticipating final readouts in Q3 CY2025.
Atomo Diagnostics Limited (ASX:AT1) Announces National Scale-Up and NZ Launch
Atomo Diagnostics (ASX:AT1) scales national HIV self-test program in Australia and expands into New Zealand through Chemist Warehouse.
Mesoblast (ASX:MSB) Announces U.S. Tariff Exemption for Allogeneic Cell Therapies
Mesoblast (ASX:MSB) announces its allogeneic cell therapies are exempt from U.S. tariffs as ‘U.S. Country of Origin’ products.
Orthocell Limited (ASX:OCC) Receives FDA Clearance for Remplir™
Orthocell (ASX:OCC) secures FDA clearance for Remplir™, enabling entry into the US $1.6 billion nerve repair market.
Echo IQ (ASX:EIQ) Partners with Mayo Clinic Platform, Advances EchoSolv HF towards FDA Clearance
Echo IQ (ASX:EIQ) partners with Mayo Clinic Platform to advance EchoSolv HF and progress towards FDA clearance for its heart failure solution.
Cann Group Limited (ASX:CAN) Executes Supply Agreements with Chemist Warehouse
Cann Group Limited (ASX:CAN) signs supply agreements with Queensland’s Chemist Warehouse outlets to distribute its medicinal cannabis products.
Race Oncology (ASX:RAC) Activates First Australian Clinical Site for RC220 Trial
Race Oncology (ASX:RAC) initiates its first Australian clinical site for the Phase 1 RC220 trial, marking a significant step in advancing cancer treatment.
Bioxyne Limited (ASX:BXN) Signs Exclusive $7M Agreement with NectarTek
Bioxyne Limited (ASX:BXN) secures a $7 million manufacturing agreement with NectarTek, significantly increasing FY2026 revenue projections.